Edgewise Therapeutics
EWTX
EWTX
72 hedge funds and large institutions have $524M invested in Edgewise Therapeutics in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
32% less capital invested
Capital invested by funds: $769M → $524M (-$246M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
72
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$10.8M | |
| 2 | +$10.5M | |
| 3 | +$6.43M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$3.46M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.39M |
Top Sellers
| 1 | -$6.17M | |
| 2 | -$3.31M | |
| 3 | -$2.25M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$902K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$415K |